Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT03892330
What this trial is testing

Combination Therapy of Anthracyclines for Children With Nephroblastoma

Who this might be right for
0.5-14 Year Old Children With Nephroblastoma
Shengjing Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00112671
What this trial is testing

Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract

Who this might be right for
Metastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+4 more
National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)Study completedNCT00738530
What this trial is testing

Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 649
Not applicableStudy completedNCT01014065
What this trial is testing

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)

Who this might be right for
Renal Cell CarcinomaCardiotoxicityHeart Failure+1 more
AHS Cancer Control Alberta 42
Large-scale testing (Phase 3)UnknownNCT00869011
What this trial is testing

Exercise for Patients With Renal Cell Cancer Receiving Sunitinib

Who this might be right for
Renal Cell Carcinoma
Charite University, Berlin, Germany 70
Not applicableUnknownNCT03259477
What this trial is testing

RFR Change of Precise Segmental Versus Complete Renal Arterial Clamping During LPN for Clinical T1 RCC

Who this might be right for
Renal Cell Carcinoma
Xuanwu Hospital, Beijing 100
Not applicableStudy completedNCT01646099
What this trial is testing

Sun Protection of Kidney Transplant Recipients

Who this might be right for
Unspecified Complication of Kidney TransplantDisorder Related to Renal Transplantation
Northwestern University 335
Early research (Phase 1)Ended earlyNCT05861947
What this trial is testing

Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Who this might be right for
RelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more
Aurigene Discovery Technologies Limited 21
Testing effectiveness (Phase 2)Ended earlyNCT00491738
What this trial is testing

A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)

Who this might be right for
Renal Cell Carcinoma
Genentech, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT02899078
What this trial is testing

Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell CancerStage IV Renal Cell Cancer
University of California, Davis 31
Early research (Phase 1)Active Not RecruitingNCT04696731
What this trial is testing

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Allogene Therapeutics 120
Not applicableStudy completedNCT01833728
What this trial is testing

A Comparison of Nefopam-propacetamol Combination and Propacetamol for Postoperative Quality of Recovery After Laparoscopic Nephrectomy

Who this might be right for
Renal Tumor
Yonsei University 16
Post-approval studies (Phase 4)Study completedNCT02596035
What this trial is testing

An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 197
Testing effectiveness (Phase 2)Looking for participantsNCT06053658
What this trial is testing

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 48
Not applicableStudy completedNCT00001668
What this trial is testing

Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors

Who this might be right for
DeafnessKidney DiseasesKidney Neoplasms+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Not applicableStudy completedNCT01649778
What this trial is testing

Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 662
Large-scale testing (Phase 3)Not Yet RecruitingNCT06959433
What this trial is testing

Lu-177 PSMA Treatment in Cell Renal Carcinoma

Who this might be right for
Metastatic Renal Cancer
Ankara University 20
Not applicableEnded earlyNCT02900248
What this trial is testing

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

Who this might be right for
NeoplasmsLung NeoplasmsColon Neoplasms+22 more
CureOne 23
Testing effectiveness (Phase 2)Ended earlyNCT00429026
What this trial is testing

Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Renal Cell Cancer
M.D. Anderson Cancer Center 40
Next Page